These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Abnormalities in Brain and Muscle Microstructure and Neurochemistry of the DMD Rat Measured by Xu S; Tang S; Li X; Iyer SR; Lovering RM Front Neurosci; 2020; 14():739. PubMed ID: 32760246 [TBL] [Abstract][Full Text] [Related]
5. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy. Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141 [TBL] [Abstract][Full Text] [Related]
6. Brain function in Duchenne muscular dystrophy. Anderson JL; Head SI; Rae C; Morley JW Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy. Wu WC; Bradley SP; Christie JM; Pugh JR J Neurosci; 2022 Mar; 42(10):2103-2115. PubMed ID: 35064002 [TBL] [Abstract][Full Text] [Related]
12. Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy. Aranmolate A; Tse N; Colognato H BMC Neurosci; 2017 Aug; 18(1):63. PubMed ID: 28806929 [TBL] [Abstract][Full Text] [Related]
13. Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits. Heier CR; Guerron AD; Korotcov A; Lin S; Gordish-Dressman H; Fricke S; Sze RW; Hoffman EP; Wang P; Nagaraju K PLoS One; 2014; 9(11):e112477. PubMed ID: 25390038 [TBL] [Abstract][Full Text] [Related]
14. Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS). Martins-Bach AB; Bloise AC; Vainzof M; Rahnamaye Rabbani S Magn Reson Imaging; 2012 Oct; 30(8):1167-76. PubMed ID: 22673895 [TBL] [Abstract][Full Text] [Related]
15. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice. Nakae Y; Stoward PJ; Kashiyama T; Shono M; Akagi A; Matsuzaki T; Nonaka I J Mol Histol; 2004 Jun; 35(5):489-99. PubMed ID: 15571326 [TBL] [Abstract][Full Text] [Related]
16. Structural and Functional Alterations of Skeletal Muscle Microvasculature in Dystrophin-Deficient mdx Mice. Latroche C; Matot B; Martins-Bach A; Briand D; Chazaud B; Wary C; Carlier PG; Chrétien F; Jouvion G Am J Pathol; 2015 Sep; 185(9):2482-94. PubMed ID: 26193666 [TBL] [Abstract][Full Text] [Related]
17. Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse. Kueh SL; Dempster J; Head SI; Morley JW Neurobiol Dis; 2011 Sep; 43(3):558-64. PubMed ID: 21601636 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy. Khattri RB; Batra A; Matheny M; Hart C; Henley-Beasley SC; Hammers D; Zeng H; White Z; Ryan TE; Barton E; Bernatchez P; Walter GA NMR Biomed; 2023 Mar; 36(3):e4869. PubMed ID: 36331178 [TBL] [Abstract][Full Text] [Related]
19. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy. Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation. Barker RG; Wyckelsma VL; Xu H; Murphy RM Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]